Robert Glaser
Cardiovascular Disease · New Hyde Park, NYNPI 1336164094
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 162 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 20 manufacturers, the largest accounting for just 15.7% — the pattern of someone who eats at a lot of different presentations. Reporting peaked in 2019 at $1,169 and has fallen 84.9% since, to $176 in 2022.
Across 162 payments — averaging $20.41 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- Johnson & Johnson$521
- E.r. Squibb & Sons, L.L.C.$414
- Merck$346
- Amgen$328
- Pfizer$321
- Novartis$284
- plus $1K from 14 others
What the payments were for
- Food & beverage$3,307100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| Johnson & Johnson | 24 | $521 |
| E.r. Squibb & Sons, L.L.C. | 16 | $414 |
| Merck | 14 | $346 |
| Amgen | 16 | $328 |
| Pfizer | 21 | $321 |
| Novartis | 16 | $284 |
| AstraZeneca | 16 | $262 |
| Boehringer Ingelheim | 11 | $242 |
| Novo Nordisk | 5 | $99 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 4 | $74 |
| Abbott | 2 | $70 |
| Insulet Corporation | 4 | $68 |
| Amarin Pharma, Inc. | 3 | $66 |
| Bayer | 2 | $45 |
| Biotronik Inc. | 1 | $38 |
| Daiichi Sankyo Inc. | 2 | $35 |
| AbbVie(2 entities) | 2 | $35 |
| Lilly USA, LLC | 1 | $25 |
| Boston Scientific | 1 | $21 |
| Kowa Pharmaceuticals America, Inc. | 1 | $14 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
How this compares
$3,307 in reported general payments places this provider in the 65th percentile of 2,302 cardiovascular disease providers in New York.
Other cardiovascular disease in New Hyde Park
- Michael LevineNew Hyde Park$267K
- Roger HajjarNew York$5.2M
- Szilard VorosStony Brook$3.7M
- Gregg StoneNew York$2M
- Augustin DelagoAlbany$1.8M
- Philippe GenereuxNew York$1.3M
- Adam RosenbluthNew York$1.1M
- Luigi di BiaseBronx$978K
- Vijay IyerAmherst$855K
- Megha PrasadNew York$813K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.